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Abstract 
 Cellular homeostasis is in part controlled by biological generated electrical activity. By 
interfacing biology with electronic devices this electrical activity can be modulated to 
actuate cellular behaviour. There are current limitations in merging electronics with biology 
sufficiently well to target and sense specific electrically active components of cells. By 
addressing this limitation, researchers give rise to new capabilities for facilitating the two-
way transduction signalling mechanisms between the electronic and cellular components. 
This is required to allow significant advancement of bioelectronic technology which offers 
new ways of treating and diagnosing diseases. Most of the progress that has been achieved 
to date in developing bioelectronic therapeutics stimulate neural communication, which 
ultimately orchestrates organ function back to a healthy state. Some devices used in 
therapeutics include cochlear and retinal implants and vagus nerve stimulators. However, 
all cells can be effected by electrical inputs which gives rise to the opportunity to broaden 
the use of bioelectronic medicine for treating disease. Electronic actuation of non-excitable 
cells has been shown to lead to ‘programmed’ cell behaviour via application of electronic 
input which alter key biological processes. A neglected form of cellular electrical 
communication which has not yet been considered when developing bioelectronic 
therapeutics is faradaic currents. These are generated during redox reactions. A precedent 
of electrochemical technology being used to modulate these reactions thereby controlling 
cell behaviour has already been set.  In this mini review we highlight the current state of 
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the art of electronic routes to modulating cell behaviour and identify new ways in which 
electrochemistry could be used to contribute to the new field of bioelectronic medicine.     
Keywords: bioelectronic interfaces, bioelectrochemistry, nanobioelectronics, cellular 
signalling  
 
The biological impact of cellular electrical activity 
Bioelectronic medicine is classically conceptualised as electronic technology that merges 
with neurons enabling control of cellular electrical communication and the underlying 
organ function. Electrical communication that is mediated by neurons is the body’s 
universal fast electrical communication system that orchestrates organ function at a macro 
level. The underlying principles of the body’s electrical communication system, from a 
traditional point of view, originates from the controlled bulk movement of ions across the 
plasma membrane of cells. This enables the establishment and modulation of membrane 
potentials and in doing so, produces an electrochemical potential gradient that can drive 
bulk charge movement. The movement of charges across the membrane lead to action 
potentials, which represent a major electrical communication route in muscle cells, 
neurons and endocrine cells (1). Other function of the membrane potential is the transport 
of molecules across it induced by the translocation of charges, or electrogenic transport. 
This includes the transport of molecules such as glucose, ATP and small peptides involved 
in a plethora of physiological roles (2-5).  
 
Importantly, all cells also use faradaic currents among other communication routes (6) to 
communicate with one another and are vital for maintaining homeostasis. Biochemical 
processes that result in the production of faradaic current, which is defined as the 
movement of electrons, are generated in redox reactions. In order for redox reactions to 
happen, an exchange of electrons between two biochemical entities, an electron donor and 
an electron acceptor, needs to be produced (Figure 1). Faradaic currents are reliant on 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
naturally occurring biological electrochemical mediators, which are defined as molecules 
that readily accept or donate an electron(s), and some of the most well known and most 
abundant are NADH, NADPH, GSH, Ascorbic acid, ubiquinone. Additionally, bio-
macromolecule such as enzymes (for example oxido-reductase) can also act as electron 
shuttles.. Examples of faradaic signalling include the generation of oxidant sources within 
the mitochondrial respiratory chain in response to bacterial infection or inflammation (7). 
Additionally, all cells useframembrane electron transport systems to shuttle electrons 
across membranes for a wide range of purposes. The electron transport via membrane 
bound systems have been implicated in cell signalling, nutrient metabolism, cell redox 
maintenance and can play an important role in disease such as cancer. Opportunities arise 
when we substitute a biological electrochemical mediator, involved in generating electrical 
faradaic current, with electrodes. This yields the ability to control redox events when 
interfacing cells with electronics by modulating the electron flow in a specific biochemical 
event via applied electrical potential stimulus, as a result leading to modulation of the 
underlying biochemistry.   
 
 
 
Despite their extensive use in cellular sensing, faradaic processes have been largely 
neglected when considering bioelectronic methods of disease intervention.  This largely 
unexplored view of cellular electrical communication, from the perspective of developing 
new bioelectronic devices, offers new opportunities in modulating cell state and therefore 
underlying cells, tissues and organ function. The aim of this mini-review is to place into 
context how this faradaic form of cellular electrical communication could be used to 
develop bioelectronic medicine. In addition to detailing the early examples of such 
technology that can interface with cells to both sense and modulate cell behaviour. 
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Development of bioelectronic therapies 
The concept of bioelectronic medicine consists of merging biological systems with 
electronic devices, allowing for the modulation of underlying cells, tissue and ultimately 
organ function by regulating electrical communication. In order to achieve efficient 
communication between biological and electronic systems, transduction of signals at the 
cellular-electronic interface must be achieved (8). This has become a key challenge in 
developing bioelectronics and is currently being explored to advance the development of 
bioelectronic devices with therapeutic interest (9). An obstacle to this is that the building 
blocks of cellular structures differ from those that can be found when constructing 
electronics, meaning that the seamless integration of electronics with biology is not yet 
possible. In addition, the plasticity of young nervous systems and tissues present a key 
obstacle as implantable electronics cannot adapt and therefore need regularly servicing. 
Advancement in manufacturing technology will aid solve this problem. For example, 
additive manufacturing techniques are particularly appealing for the production of novel 
three-dimensional bioelectronic tools, allowing a synergistic integration of electronic 
components with the biological building blocks (10). This is due to their capability of 
combining conductive materials and living cells in unique architectures, resulting in 
functional devices (11, 12). Therefore, there are technical challenges which require 
solutions, from physicists, chemists, engineers and biologists.  
 
However, significant progress has been made with several electronic devices successfully 
introduced as therapeutics aimed to palliate disabilities, and consequently become good 
examples of an effective transduction of signals. Examples include known cochlear or 
retinal implants where sound and light, respectively, are converted into electrical signals 
that can be transmitted to the nervous system and interpreted by the patient’s brain (13, 
14). 
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Stimulation of nerve fibres based on direct vagus nerve stimulation is also gaining interest 
as a treatment of rheumatoid arthritis and metabolic syndrome (15-17) (Figure 2). This 
therapeutic strategy demonstrates the influence of the nervous system over the different 
biological functions and disease state. Further investigation in this regard can possibly 
decode the neural circuits and how nerve stimulation correlates to the homeostatic state 
of an organism, leading to new means of treating and diagnosing disease. Similar devices 
based on the depolarisation of the sinus node to induce action potentials can be found for 
excitation of cardiac cells in the therapy of heart failure and atrial fibrillation (18). 
  
 
Currently electrical stimulation with these devices is unable to target cells individually, 
inducing the excitation of the whole tissue. Due to the highly compact state of the nervous 
and cardiac systems, indiscriminate stimulation can lead to undesirable effects or mire the 
clinical outcomes.  Application of inputs on specific cells would be beneficial to achieve a 
fine degree of regulation. Advances in nanotechnology have contributed to the 
development of structures such as nano-field effect transistors (nano-FETs) or nanowires 
(NWs) capable of stimulate and record signals from individual cells, increasing the 
prospects of targeting intracellular components (19, 20). It is therefore envisaged that 
future advancements in this technology will aid in the development of bioelectronic 
therapeutics aimed at increasing the selectivity and specificity of cellular control. 
 
Reaching non-excitable cells 
Cells that are unable to propagate action potentials, known as non-excitable cells, also 
possess electrical properties and endogenous electric fields to direct growth or healing 
(21). Interfacing these cells with electronic devices gives rise to new opportunities that 
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should allow for the control of cellular function. This natural bioelectric behaviour can be 
organised and stimulated by applying electric currents that control the polarisation of the 
membrane potential. This induced transmembrane potential can regulate the passage of 
molecules and ions across it by, for instance, controlling Ca2+ and epidermal growth factor 
receptor (EGFR) channels (22). Defective ion and molecular transport have implications 
on diverse diseases such as cancer or pulmonary oedema (23, 24). Therefore, achieving 
good degree of control of transport across the cellular membrane could have great 
repercussions in the treatment of these diseases. Application of exogenous electric fields 
has been demonstrated to be effective in both single cells and tissues, triggering a wide 
range of biological actions (25) (Figure 3). 
 
 
Due to the high resistance of the cellular membrane to current flow, ionic currents induced 
by artificial external electric fields are forced to surround the cells, imposing a potential 
gradient across the membrane surface. This potential gradient induces changes in function 
and/or orientation of membrane proteins and opening of ionic channels, leading to 
stimulation of intracellular signalling pathways (26). The signalling cascade alters 
expression of genes which code for proteins involved in several biological functions 
including cell division, migration, proliferation and embryogenesis. 
 
The gap junctions between cells, which are channels connecting cellular cytoplasms, also 
have an important role when applying electric fields in order to generate a response at a 
tissue level. This slow communication route can amplify the intracellular signalling cascade 
produced in response to the changes in the potential (21). Signals propagate through the 
tissue, triggering a coordinated cellular response, for example to wound healing or tissue 
regeneration. This approach has been introduced in the therapy of bone fracture healing 
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and osteoarthritis, stimulating the chondrocyte and osteoblast regeneration. As a result, 
osteogenesis and increases on bone mineral density can be observed (27). 
 
Cancer therapy can also be benefited from the use of electric fields. There have been many 
studies reporting the differences in resting membrane potentials between tumour and non-
tumour cells. Generally it can be established that cells with a high proliferative activity 
such as embryonic, stem and metastatic cells possess a depolarised membrane (28). 
Metastatic phenotypes can be induced in healthy cells by depolarisation of their membrane 
and conversely, the activity in a metastatic cell induced by oncogenes can be supressed 
by preventing its depolarisation (21).  
 
Additional research in this area will allow a deeper understanding of the precise 
mechanisms involved, which may make it possible to program cellular activity via use of 
electric fields. Importantly this broadens the prospective applications of bioelectronic 
medicine beyond neural control. 
 
Improving electronic targeting: an electrochemical approach 
In order to create bioelectronic tools with such capabilities in cell programming, further 
specificity on the cellular outputs is desirable. Biomolecular entities, including redox 
biomolecules, are known to be highly specific as they represent a transfer system of 
biological information. Therefore, controlling faradaic currents involved in cellular redox 
reactions offers opportunities for the electrochemical mediated induced control of cells, 
tissues and organ function.  
 
The faradaic processes can be hijacked by modulation of polarity or by using 
electrochemically active molecules. Electronic inputs are transduced into redox active 
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mediators that ultimately activate a biological mechanism (Figure 4). Biological 
responses often correlates with the magnitude, frequency, and/or type of electronic input 
applied (29), indicating that a fine degree of control can be achieved. For this reason, the 
authors believe that bioelectrochemical devices with ability to control cell function and 
disease state can be included in the field of bioelectronic medicine (30). 
 
 
Figure 4. Transduction of signals on a bioelectrochemical system. An electronic input in 
the form of potential modulates the redox state of naturally occurring electrochemical 
mediators, from an inactive state to an active state or vice versa, and are communicated 
to a cellular system triggering biological response (41).  
 
Formation of effective interfaces between electrodes and cells is possible by engineering 
the electrode surface at the nanoscale. This gives rise to potential for sensing and 
controlling faradic processes and has been reviewed recently (31, 32). In general, 
approaches to electrically ‘wire’ cell redox components rely on electrode modification with 
conducting polymers (33), nanowires based  on carbon nanofibers (34), carbon nanotubes 
(35, 36)  and electrocatalysts (37).  This wiring can also be achieved via modification of 
electrode surfaces with chemical entities that bond to the saccharide groups of the 
eukaryotic cells that facilitate electron transfer (38). In addition, structures integrated with 
biological components such as enzymes, lipid bilayers or antibodies are used to transduce 
ions into electrical currents and vice-versa for recording and stimulation of biological 
reactions in both intracellular and extracellular environments (39). For instance, electrodes 
can be conjugated with neurotransmitters to induce neural excitability (40) or regulate pH 
using protonic devices to control enzymatic function, and acid sensitive ion channels (39).  
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Future opportunities in directing cell behaviour electrochemically  
Reactive oxygen species (ROS) may be used to direct cell function. ROS are involved in 
signalling pathways that take part in several biological events associated to bacterial 
infection and cancer. The production of ROS can be controlled by electrochemical 
generation (37). Gene transcription can be induced in response to oxidative stress, 
inducing cell motility or cell-to-cell communication (41).  Therefore electrochemical control 
of ROS generation may prove fruitful for directing cell behaviour. 
 
Further development of bioelectrochemical devices may have great implications in future 
cancer therapy by individually controlling plasma membrane electron transport systems 
(tPMETs). The system of tPMET ferri-reductase is upregulated and it is thought to enable 
faster rates of metabolism in cancer cells (30). Therefore, electrochemical tools with 
capacity to control such systems may regulate metabolism and cellular development. 
 
Conclusions 
Bioelectronic medicine is a growing field where major advancements in treatment and 
diagnosing of diseases are being achieved. Therapies based on neural stimulation and 
application of electric fields are currently used to improve patient’s quality of life, but 
additional control of the effects is still required.  
 
The main challenges include creation of effective biological-electrical interfaces and 
transduction of signals. In order to modulate the electron transfer events, an intimate 
contact of the electronic component with the active sites is required. Therefore, 
technological advancements in the interfacing of electronics with such active sites are 
necessary to fully integrate biological systems and electronic devices.  
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Further specificity can also be achieved by controlling redox biomolecules and the 
biological output with great precision, adding new proportions to the bioelectronic medicine 
field. However, bioelectrochemical therapies still require a multidisciplinary approach to 
produce less invasive techniques, e.g. using wireless systems. In order to achieve this, 
development of nanotechnology, materials and new methodologies will greatly contribute 
to this field offering new therapeutic tools.  
 
A more thorough understanding and controlled targeted stimulation of vagus nerve, in 
addition to ROS production could be used to control of inflammatory mediators that take 
part in diseases such as artherosclerosis, pulmonary fibrosis, Parkinson’s disease and 
Alzheimer’s disease. Cancer therapy can also be impacted by development of 
bioelectrochemical systems to direct tPMET activity, regulating cellular behaviour.  
 
It can thus be concluded that this field has many open paths and offers many exciting 
approaches and research opportunities that will contribute to create great impact over the 
future medicine and pharmacology. 
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Figure 1. Bulk ion vs faradaic conductance across the cell plasma membrane. Ionic 
currents are produced by the movement of charges across the membrane through the 
ionic channels, whereas faradaic currents are produced by the movement of electrons 
between electrochemical mediators.  
Figure 2. Schematic representation of a bioelectronic approach targeting the vagus nerve 
to control inflammation. Vagus nerve signalling interacts with the splenic nerve that 
reaches splenic T cells that produce acetylcholine, which reduces inflammation.   
Figure 3. Different biological functions can be triggered by the application of electric fields 
and these include actuating cell movement, modulating the cell cycle which benefits wound 
healing and tissue regeneration. Currents can polarise a) single cells and b) tissues. Black 
arrows indicate the direction of the electrical currents whereas red arrows indicate the 
direction of the resulting polarised behaviour (25).  
Figure 4. Transduction of signals on a bioelectrochemical system. An electronic input in 
the form of potential modulates the redox state of naturally occurring electrochemical 
mediators, from an inactive state to an active state or vice versa, and are communicated 
to a cellular system triggering biological response (41).  
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